theory clinical_14_8
imports Main

begin

typedecl entity
typedecl event

consts
  BRCA2 :: "entity ⇒ bool"
  RAD51 :: "entity ⇒ bool"
  Repair :: "entity ⇒ bool"
  Humans :: "entity ⇒ bool"
  Involved :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  In :: "event ⇒ entity ⇒ bool"
  Molecules :: "entity ⇒ bool"
  Binding :: "event ⇒ bool"
  Joining :: "event ⇒ bool"
  Promotion :: "event ⇒ bool"
  Catalyze :: "event ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Essential :: "event ⇒ bool"
  For :: "event ⇒ event ⇒ bool"
  Interaction :: "event ⇒ bool"
  Promote :: "event ⇒ bool"
  Occur :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"

(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair in humans. *)
axiomatization where
  explanation_1: "∃x y z e1. BRCA2 x ∧ RAD51 y ∧ Repair z ∧ Humans z ∧ Involved e1 ∧ Agent e1 x ∧ Agent e1 y ∧ In e1 z"

(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules, and this binding is essential for the promotion of joining undamaged homologous repair molecules. *)
axiomatization where
  explanation_2: "∃x y z e1 e2 e3. BRCA2 x ∧ RAD51 y ∧ Molecules z ∧ Binding e1 ∧ Joining e2 ∧ Promotion e3 ∧ Agent e1 x ∧ Agent e1 y ∧ Catalyze e1 ∧ Patient e1 z ∧ Essential e1 ∧ For e1 e3"

(* Explanation 3: BRCA2, through its interaction with RAD51 homolog 1, promotes the joining of undamaged homologous repair molecules in humans, and this interaction is essential for the promotion process. *)
axiomatization where
  explanation_3: "∃x y z e1 e2 e3. BRCA2 x ∧ RAD51 y ∧ Molecules z ∧ Humans e2 ∧ Interaction e1 ∧ Joining e3 ∧ Promotion e3 ∧ Agent e1 x ∧ Via e1 y ∧ Promote e1 ∧ Patient e1 z ∧ In e1 e2 ∧ Essential e1 ∧ For e1 e3"

(* Explanation 4: The promotion occurs via RAD51 homolog. *)
axiomatization where
  explanation_4: "∃x e. Promotion e ∧ RAD51 x ∧ Occur e ∧ Via e x"

theorem hypothesis:
  assumes asm: "BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e2"
  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)
  shows "∃x y z e1 e2. BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e2 ∧ Joining e1 ∧ Agent e1 y ∧ Patient e1 y ∧ Promote e1 ∧ Agent e1 x ∧ Via e1 z ∧ In e1 e2"
proof -
  (* From the premise, we have known information about BRCA2, Molecules, RAD51, and Humans. *)
  from asm have "BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e2" by meson
  (* Explanation 3 states that BRCA2, through its interaction with RAD51 homolog 1, promotes the joining of undamaged homologous repair molecules in humans. *)
  (* This interaction is essential for the promotion process. *)
  (* We can use the logical relation Implies(F, G) and Implies(G, H) to infer the promotion process and that it occurs via RAD51 homolog. *)
  from explanation_3 have "∃e1 e3. Interaction e1 ∧ Joining e3 ∧ Promotion e3 ∧ Agent e1 x ∧ Via e1 z ∧ Promote e1 ∧ Patient e1 y ∧ In e1 e2 ∧ Essential e1 ∧ For e1 e3" sledgehammer
  (* From this, we can infer the existence of a joining event e1 and a promotion event e3. *)
  then have "∃e1. Joining e1 ∧ Agent e1 y ∧ Patient e1 y ∧ Promote e1 ∧ Agent e1 x ∧ Via e1 z ∧ In e1 e2" <ATP>
  then show ?thesis <ATP>
qed

end
